Simbionix Relocates its Courseware Business to its Corporate Headquarters in Cleveland, Ohio
CLEVELAND, Ohio, August 16, 2010 /PRNewswire/ -- Simbionix USA
Corporation, the world's leading provider of medical education and simulation
training products for medical professionals and the healthcare industry, will
consolidate its eTrinsic custom courseware business currently located in
Denver, Colorado and relocate those operations to its Corporate Headquarters
in Cleveland, Ohio under its expanding Medical Education Division (MED).
The move will enable Simbionix to better focus on its strategic
direction, enhance its mobile and web-based medical education products and
services, and improve reaction to customer and market needs. "This is a very
exciting time for Simbionix", stated Paul Jensen, the GM of the new and
expanding Medical Education Division, "we are developing a number of
innovative products. Having everyone in one location will facilitate
collaboration across the team and improve our ability to rapidly deliver
The company recently announced the expansion of its Corporate
Headquarters. The move will be completed by the end of September 2010.
About Simbionix USA Corporation
Simbionix is the world's leading provider of simulation and training
products for medical professionals and the healthcare industry. Founded in
1997, the company is committed to delivering high quality products, advancing
clinical performance and optimizing procedural outcomes.
(Date:12/8/2016)... ... December 08, 2016 , ... The ability ... optogenetics — is key to exciting advances in the study and mapping of ... projected via free-space optics stimulates small, transparent organisms and excites neurons within superficial ...
(Date:12/8/2016)... Oxford Gene Technology ... Palette an anpassbaren SureSeq™ NGS-Panels mit dem Start ... ein schnelles und kostengünstiges Studium der Varianten bei ... Erkennung von Einzel-Nukleotid-Variationen (Single Nucleotide Variation, SNV) und ... Panel und ermöglicht eine individuelle Anpassung durch die ...
(Date:12/8/2016)... Anaconda BioMed S.L., a pre-clinical stage medical device ... neuro-thrombectomy system for the treatment of Acute Ischemic Stroke ... to join its Scientific Advisory Board (SAB). The SAB ... scientific and clinical experts to Anaconda BioMed S.L., as ... ® to its clinical phase. The SAB is ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... announces the commercial launch of flexible packaging for their exceptionally efficient human ... bag system extends RoosterBio’s portfolio of bioprocess media products engineered to radically ...
(Date:12/7/2016)... According to a new market research report "Emotion Detection and Recognition Market ... Application Area, End User, And Region - Global Forecast to 2021", published by ... 2016 to USD 36.07 Billion by 2021, at a Compound Annual Growth Rate ... ... MarketsandMarkets Logo ...
(Date:12/6/2016)... Valencell , the leading innovator in ... a third consecutive year of triple digit growth for ... with a 360 percent increase in companies who have ... driven by sales of its wrist and ear Benchmark™ ... technology for hearables for fitness and healthcare applications. ...
(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we spend ... recovery so we need to do it well. Inadequate sleep levels have been found ... pressure, stroke, diabetes, and even cancer. Maybe now is the best time ... could help them to manage their sleep quality? Continue ... ...